• 1. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 2. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 3. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 4. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
• 5. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548

Comprehensive Overview of 4-Amino-1-[7-hydroxy-1-(hydroxymethyl)-2,5-dioxabicyclo[2.2.1]heptan-3-yl]pyrimidin-2-one (CAS No. 206055-69-8)

4-Amino-1-[7-hydroxy-1-(hydroxymethyl)-2,5-dioxabicyclo[2.2.1]heptan-3-yl]pyrimidin-2-one, with the CAS number 206055-69-8, is a specialized organic compound that has garnered significant attention in pharmaceutical and biochemical research. This compound features a unique bicyclic structure combined with a pyrimidinone moiety, making it a subject of interest for its potential applications in drug development and molecular biology. Researchers are particularly intrigued by its structural complexity, which offers opportunities for novel therapeutic agents.

The 2,5-dioxabicyclo[2.2.1]heptane core in this molecule is a key structural feature, contributing to its stability and reactivity. This bicyclic framework is often explored in the design of prodrugs and enzyme inhibitors due to its ability to mimic natural sugar analogs. The presence of the 4-aminopyrimidin-2-one group further enhances its biological relevance, as this moiety is commonly found in nucleobases and antiviral compounds. Such characteristics make CAS 206055-69-8 a valuable candidate for studies targeting metabolic pathways and nucleic acid interactions.

In recent years, the demand for high-purity biochemical intermediates like 4-Amino-1-[7-hydroxy-1-(hydroxymethyl)-2,5-dioxabicyclo[2.2.1]heptan-3-yl]pyrimidin-2-one has surged, driven by advancements in personalized medicine and targeted therapies. Scientists are investigating its role in modulating enzymatic activity and its potential as a building block for next-generation pharmaceuticals. The compound's solubility and stability under physiological conditions are also critical factors being evaluated for in vivo applications.

From a synthetic chemistry perspective, the preparation of CAS 206055-69-8 involves multi-step organic reactions, often requiring precise control over stereochemistry and functional group compatibility. Researchers frequently employ protecting group strategies and catalytic asymmetric synthesis to achieve high yields and enantiomeric purity. These methodologies are essential for ensuring the compound's suitability in high-throughput screening and structure-activity relationship (SAR) studies.

The growing interest in bioactive heterocycles has positioned 4-Amino-1-[7-hydroxy-1-(hydroxymethyl)-2,5-dioxabicyclo[2.2.1]heptan-3-yl]pyrimidin-2-one as a focal point in medicinal chemistry. Its potential applications span antiviral, anticancer, and anti-inflammatory research, aligning with current trends in drug repurposing and combination therapies. As the scientific community continues to explore its mechanisms of action, this compound is expected to play a pivotal role in the development of innovative treatments for complex diseases.

For laboratories and institutions engaged in cutting-edge research, sourcing high-quality CAS 206055-69-8 is paramount. Suppliers must adhere to stringent quality control standards, including HPLC purity verification and mass spectrometry characterization, to meet the demands of academic and industrial researchers. The compound's versatility and potential for customization further underscore its value in custom synthesis and preclinical development pipelines.

In summary, 4-Amino-1-[7-hydroxy-1-(hydroxymethyl)-2,5-dioxabicyclo[2.2.1]heptan-3-yl]pyrimidin-2-one (CAS 206055-69-8) represents a compelling area of study at the intersection of chemistry and biology. Its unique structural attributes and broad applicability make it a standout candidate for future breakthroughs in therapeutic innovation and biomolecular engineering. As research progresses, this compound is poised to contribute significantly to the evolving landscape of precision medicine and biopharmaceuticals.

• 2140-72-9(2'-O-Methylcytidine)
• 32830-01-6(4-amino-1-(2,5-anhydropentofuranosyl)pyrimidin-2(1H)-one)
• 444020-09-1(3'-Deoxy-3'-C-methylcytidine)
• 223777-16-0(2'-O-(2-Methoxyethyl)-cytidine)
• 62529-10-6(Cytidine, 2-O-ethyl-)
• 68707-89-1(Cytidine, 4'-C-(hydroxymethyl)-)
• 20724-73-6(NM107)
• 34989-27-0(2(1H)-Pyrimidinone,4-amino-1-(2,3-anhydro-b-D-lyxofuranosyl)-)
• 20724-72-5(Cytidine, 3'-C-methyl-)
• 133713-59-4(3'-deoxy-3'-(hydroxymethyl)cytidine)